Synchronous Adenocarcinoma and Neuroendocrine Tumors of the Stomach by Mitchell, Michelle Selma et al.
Ivy Union Publishing | http: //www.ivyunion.org August 13, 2015 | Volume 4, Issue 2 
Mitchell MS et al. American Journal of Cancer Case Reports 2016, 4:125-128
6
Page 1 of 4 
 
 
Synchronous Adenocarcinoma and 
Neuroendocrine Tumors of the Stomach 
 
Michelle S. Mitchell1; Lesley Walinchus-Foster1; Lisa Thomas, MD1; Qi Shi, 
MD2*; Maria Nagori, MD2; Waheed Khan, MD2; Wasique Mirza, MD2;  
Michael Cortes, MD2; Ossama Al Masalmeh, MD2; Hasan Zerti, MD2;  
and Abdulla Mohamed, MD2 
 
1
The Commonwealth Medical College, Scranton, PA, USA 
2
 Department of Internal Medicine, The Wright Center for Medical Graduate Education, 
Scranton, PA, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Case Report 
 
 
 
 
 
 
 
Keywords: Gastric adenocarcinoma; synchronous tumors; neuroendocrine; carcinoid; malignancy 
Academic Editor: Xiaoning Peng, Hunan Normal University School of Medicine, China 
Received: June 11, 2016; Accepted: July 30, 2016; Published: August 13, 2016 
Competing Interests: The authors have declared that no competing interests exist.  
Consent: Consent was taken from the patient for publication of this case report.  
Copyright: 2016 Shi Q et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited.  
*Correspondence to: Qi Shi, Department of Internal Medicine, The Wright Center for Medical Graduate Education, 
Scranton, PA, USA 
Email: shiq@thewrightcenter.org 
Abstract  
Introduction: Synchronous tumors of the stomach have been reported in a limited number of case reports in the 
literature. Gastric neuroendocrine tumors are uncommon and account for 0.3% of gastric neoplasms. The coexistence of 
adenocarcinoma and carcinoid tumors in the stomach is exceedingly rare.   
Presentation of Case: We report a rare case of two primary, histologically distinct, synchronous cancers of the stomach 
in a 70-year-old male. The patient presented for evaluation of a pre-syncopal episode. Lab data confirmed a 
normocytic/normochromic anemia with a hemoglobin of 6.6 g/d, hematocrit of 20.3%, and MCV of 86.1fL. An EGD was 
completed which demonstrated a 30 mm polypoid ulcerative mass in the gastric antrum and a 12 mm polyp in the gastric 
body. Pathological assessment confirmed adenocarcinoma and neuroendocrine (carcinoid) malignancies respectively. 
Conclusion: There have been limited case reports of patients with two separate, synchronous gastric 
malignancies. Additional reports of these cases would be necessary so appropriate screening and surveillance 
recommendations can be established, particularly if there is a coexistent history of autoimmune disease.   
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Introduction 
Gastric cancer is one of the most common cancers in the world [1], with gastric adenocarcinoma accounting 
for 95% of malignant gastric neoplasms [2]. Gastric neuroendocrine tumors are uncommon and account for 
0.3% of gastric neoplasms [3]. The coexistence of adenocarcinoma and neuroendocrine carcinoid tumors in 
the stomach is exceedingly rare [4]. We report a case of two synchronous gastric malignancies in a patient 
who had a history of chronic gastritis and pernicious anemia.  
Case Presentation 
A 70 year-old Caucasian male presented to the emergency department for evaluation of a pre-syncopal 
episode. He complained of a several month history of generalized weakness and dizziness, along with an 
unintentional 20 pound weight loss. In addition, he complained of constipation, but denied nausea, 
vomiting, melena or hematochezia. He had no flushing, wheezing, or diarrhea complaints. His past 
medical history included iatrogenic hypothyroidism, diabetes mellitus, pernicious anemia, and vitiligo. 
His prescribed medications included atorvastatin, carvedilol, cyanocobalamin intramuscularly, 
glimepiride, furosemide, metformin, levothyroxine, and metoprolol. However, he had not refilled his 
medications for several months due to financial limitations. Examination of the patient revealed 
conjunctival pallor, vitiligo cutaneous changes, diffuse erythematous papules on his upper and lower 
extremities with multiple engorged cimex lectularius (bedbugs) and Leser-Trélat sign. Lab abnormalities 
confirmed a hemoglobin of 6.6 g/dL (14.0-18.0 g/dL), hematocrit 20.3% (42.0-52.0%), MCV 86.1 fL 
(80-94 fL), iron 42 μg/dL (50-212 μg/dL), ferritin 7.6 ng/mL (23.9-336.2 ng/mL), vitamin B12 145 
pg/mL (180-914 pg/mL), TSH 48.92 μU/mL (0.34-5.6048.92 μU/mL) and blood glucose level of 372 
mg/dL (70-105 mg/dL).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1 (left) Upper endoscopy showing the polypoid mass 
Fig 2 (right) Upper endoscopy showing polyp in the gastric body 
To further evaluate the concomitant iron and vitamin B12 deficiency anemias and due to his weight 
loss complaint, a CT of the abdomen  was completed that demonstrated mild to moderate wall 
thickening of the gastric antrum with no evidence of liver metastasis or significant lymphadenopathy. An 
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upper endoscopy was performed to rule out malabsorption and bleeding. A 30 mm polypoid ulcerative 
antral mass and a 12 mm polyp in the gastric body were identified. Pathological assessment confirmed 
gastric adenocarcinoma and a neuroendocrine tumor (carcinoid) respectively. The patient had completed a 
recent colonoscopy which was unremarkable so an additional procedure was not recommended. The 
patient underwent a Billroth I distal gastrectomy and was subsequently discharged to a nursing facility for 
rehabilitation on post-operative day seven.    
Pathological Findings 
Analysis of the 30 mm polypoid ulcerative mass in the gastric antrum revealed moderately differentiated 
adenocarcinoma infiltrating into the lamina propria and focally reaching in sections to the edge of the 
muscularis mucosa. The cells were strongly positive for p53 and the giemsa stain for H. pylori was 
negative.  
 
 
 
 
 
 
 
Fig 3 (left) Well to moderately differentiated invasive adenocarcinoma of the antrum polyp (hematoxylin-eosin stain) 
Fig 4 (right) Immunohistochemical staining for chromogranin of the gastric body polyp (original magnification x40) 
The 12 mm polyp in the gastric body revealed a gastric neuroendocrine tumor grade 1. 
Immunohistochemical staining was performed which was positive for synaptophysin, chromogranin, and 
focally positive for the AE1/AE3 and NSA. The cells were negative for gastrin and the mitotic activity 
index (Ki67) was less than 2% of the malignant cells.  
Final pathology resulted in a 0.8 cm moderately-differentiated adenocarcinoma, intestinal type, in 
the gastric antrum invading the submucosa with negative margins and 0 of 11 lymph nodes involved. 
Pathologic staging was pathologic pT1b pN0. A 1.5mm carcinoid tumor was present near the proximal 
margin of the resection.  
Discussion 
There has been limited case reports of synchronous gastric malignancies reported in the literature [4, 5, 6, 7, 
8]. Gastric neuroendocrine tumors are rare, and the incidence of gastric neuroendocrine tumors coexisting 
with other tumors of the stomach is exceptionally uncommon. 
The patient discussed had several risk factors for developing gastric carcinoma. Pernicious anemia, 
which is associated with atrophic gastritis, is linked to gastric adenocarcinoma and gastric carcinoid type 1, 
and is associated with a sevenfold relative risk of developing gastric cancer [9]. Additionally, there is 
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evidence that atrophic body gastritis and autoimmune thyroid diseases can occur in a closely linked fashion, 
as seen in this patient [10]. 
People with one autoimmune disease are more prone to developing another. As the patient had several 
autoimmune disorders, we sought to determine if there was a cohesive diagnosis. Based on the patient’s 
past medical history of several autoimmune disorders, including pernicious anemia, vitiligo, autoimmune 
thyroiditis, and type 2 diabetes mellitus, the patient met the criteria of autoimmune polyendocrine 
syndrome (APS) type 3. The clinical classification of APS was originally described by Neufeld 1980 and 
suggested classifying APS into three main types [11]. APS-3 is characterized by the presence of an 
autoimmune thyroid disease and another autoimmune disease, excluding Addison’s disease.  
Conclusion 
Published case reports that describe the occurrence of two pathologically distinct synchronous cancers of 
the stomach are limited. Additional case reports are necessary so that appropriate screening and 
surveillance recommendations can be established, particularly if there is a coexistent history of 
autoimmune disease.   
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